News

The Japan patent covers Rexahn’s preclinical compound RX-0047 and a method of inhibiting the expression of HIF-1 in human cells or tissues. HIF-1, a human protein is involved

Theobromine, a metabolite of caffeine, has been used as a vasodilator (a blood vessel widener), a diuretic (urination aid) and heart stimulant. Theobromine has been shown to inhibit

Alferon N Injection is Hemispherx’s natural FDA approved interferon injection product for a category of sexually transmitted diseases in Argentina with an option for other Latin American countries

Glenmark‘s extended-release Felodipine tablets are available in strengths of 2.5 mg, 5 mg and 10 mg and are indicated for the treatment of hypertension. Glenmark will commence marketing

Pristine Pharma, a wholly owned subsidiary of Michelex, is planning to produce cough syrups, pain relievers, nasal sprays and other liquid OTC medicines under store brand labels, and

The two grants totaling were awarded to ExonHit by the US Secretary of Health and Human Services to support its Alzheimer’s disease and oncology research and development projects.

The Phase I trial for AC430 is a two part, placebo-controlled, single ascending, and multiple ascending dose trial in healthy volunteers. In the trial, AC430 will be administered

Eisai has submitted an application to the Japanese Ministry of Health, Labour and Welfare on 28 April 2010, seeking approval of additional twice-daily dosage and administration of Pariet

Biogen Idec will make an initial payment of $32.5m and up to $395m in contingent payments. Biogen Idec and Neurimmune said that the acquisition builds on a 2007